How Diabetes Affects Implant Eligibility and Healing

Patients with diabetes frequently arrive at an implant consultation expecting to be told no. Some have already been told no elsewhere, occasionally on the basis of the diagnosis alone rather than any assessment of how well the condition is controlled.

That is not the current position. Diabetes is not a contraindication to implant treatment. What it is, is a factor that changes the assessment, the planning, the likely timescales and the maintenance that follows — and one where the level of control matters considerably more than the label.

Osseointegration — the formation of a direct structural connection between bone and the implant surface — depends on a sequence of biological events. Clot formation, an inflammatory phase, migration of bone-forming cells, formation of woven bone and its remodelling into organised lamellar bone.

Several of these are influenced by hyperglycaemia.

Microvascular changes. Sustained high blood glucose damages small blood vessels, reducing perfusion of the tissues. Both bone formation and soft tissue healing depend on an adequate blood supply.

Advanced glycation end products. Glucose binds non-enzymatically to proteins, producing AGEs that accumulate in tissues. These interfere with collagen function, alter bone quality and promote inflammatory signalling through their receptor, RAGE.

Altered bone turnover. Hyperglycaemia is associated with reduced osteoblast activity and altered osteoclast function, which affects both the formation and the remodelling phases of integration.

Impaired neutrophil function. Chemotaxis, phagocytosis and bacterial killing are all reduced at elevated glucose levels, which affects resistance to infection at the surgical site and, later, around the restored implant.

Collagen metabolism. Both the production and the maturation of collagen are affected, which influences soft tissue healing and the quality of the seal that forms around the implant.

Importantly, these effects relate to hyperglycaemia rather than to the diagnosis. A person with well-controlled diabetes has, biologically, a very different healing environment from someone with the same diagnosis and poor control.

This is an area where the research has shifted meaningfully over time.

Early studies, conducted when glycaemic control was generally less good and implant surfaces were smoother, reported notably worse outcomes in diabetic patients. More recent work, in patients with reasonable control and using modern roughened implant surfaces, has generally found survival rates approaching those in patients without diabetes.

What the literature does consistently suggest:

• Well-controlled diabetes is associated with implant survival rates comparable to those in non-diabetic patients.

• Poorly controlled diabetes is associated with higher rates of early failure, delayed healing and post-operative infection.

• Integration takes longer. Studies using resonance frequency analysis have shown that implant stability takes longer to develop in diabetic patients, which has direct implications for loading protocols.

• Peri-implantitis risk is higher, particularly with poorer control. This is the more significant long-term issue, and it mirrors the well-established relationship between diabetes and periodontitis.

The last point deserves emphasis. The question is not only whether the implant integrates. It is whether it remains healthy over the following decades, and that is where diabetes has its more persistent influence.

HbA1c reflects average blood glucose over roughly the preceding two to three months, which makes it the most useful single measure for surgical planning.

There is no universally agreed threshold above which implant treatment is contraindicated, and any figure quoted as an absolute cut-off should be treated with caution. What is broadly accepted is a graded picture:

• Well-controlled diabetes — generally understood as HbA1c below around 7 per cent, or 53 mmol/mol — is associated with outcomes close to those in non-diabetic patients, and treatment proceeds with standard planning plus attentive maintenance.

• Moderately controlled diabetes is associated with slower integration and somewhat higher complication rates. Treatment is often appropriate with extended healing periods, avoidance of immediate loading, and closer review.

• Poorly controlled diabetes carries a materially higher risk of early failure and infection. The usual recommendation is to work with your diabetes team to improve control before elective surgery rather than to rule treatment out permanently.

This is a discussion involving your GP or diabetes care team as well as the dental team. A recent HbA1c result is one of the more useful things to bring to an implant consultation.

Type and duration of diabetes. Type 1, type 2, or other. Longer duration is associated with more established microvascular change.

Glycaemic control, including recent HbA1c results and the pattern over time rather than a single reading.

Complications. Retinopathy, nephropathy and neuropathy indicate the extent of microvascular involvement.

Medications, including insulin regimens and oral agents. Some diabetes medications have implications for surgical scheduling and for hypoglycaemia risk during longer appointments.

Other risk factors, particularly smoking, which compounds the risk considerably. Our article on implants for smokers covers the evidence.

Periodontal status. Periodontitis and diabetes have a bidirectional relationship, and active periodontal disease must be treated and stabilised before implants are placed. Our article on whether gum disease can be reversed covers what is achievable.

Bone volume and quality, assessed with a CBCT scan.

Your ability to maintain the result, since maintenance carries more weight here than in most cases.

Our article on borderline implant candidacy sets out the broader assessment framework, and our article on implants with controlled diabetes covers the treatment experience.

Timing of appointments. Surgery is often scheduled in the morning, when endogenous cortisol is higher and glycaemic control tends to be more stable, and to avoid disrupting meal and medication timing.

Blood glucose measured on the day. Before surgery, and sometimes afterwards. If it is significantly outside the expected range, postponing is usually the right decision.

Meal and medication planning. You should eat normally and take your medication as usual unless specifically instructed otherwise. Extended appointments may require a break.

Antibiotic prophylaxis. Sometimes considered where control is less good, though practice varies and it is not universal. It is a clinical judgement made case by case.

Extended healing periods. Because integration takes longer, healing periods are commonly lengthened before the implant is loaded. Immediate loading protocols are generally avoided where control is not good.

Attention to soft tissue handling. Atraumatic technique and careful flap management matter more where healing is compromised.

Staged treatment. Where extensive work is planned, breaking it into stages reduces surgical burden and allows healing to be assessed before proceeding.

Recovery follows the same sequence as in any patient, but with some differences in emphasis.

Soft tissue closure may take slightly longer. Integration is slower, which is why the wait before the definitive restoration is often extended. The stability dip that occurs in the weeks after placement, as primary mechanical stability gives way to biological stability, is the period of greatest vulnerability — our article on the implant healing phase between weeks two and four explains this.

Signs to report promptly: increasing rather than decreasing pain, swelling that worsens after the first week, discharge, fever, or any sense of movement in the implant. Report these earlier rather than later, since infection has more scope to progress where neutrophil function is reduced.

Seek urgent care if swelling is spreading, if you have a fever with facial swelling, or if you have difficulty swallowing or breathing. In an emergency, call 999 or attend an emergency department.

This is where the greatest difference lies, and it is a lifelong commitment rather than a phase.

• More frequent professional maintenance, often three-monthly rather than six-monthly, with probing and periodic radiographs to detect bone change early.

• Meticulous daily cleaning around the implant and beneath the restoration. Our articles on electric toothbrushes and implants and water flossers cover technique.

• Continued glycaemic control, which remains relevant long after the surgery is over.

• Prompt reporting of any bleeding or discomfort, since peri-implant mucositis is the reversible stage and peri-implantitis is not. Our article on gum pain around an implant covers the signs.

• Attention to dry mouth, which is common in diabetes and increases plaque retention. Our article on dry mouth and implant failure explains the mechanism.

Can I have dental implants if I have type 2 diabetes?

In many cases yes, particularly where glycaemic control is good. The diagnosis alone does not rule treatment out. What determines suitability is the level of control, the presence of complications, periodontal status, other risk factors such as smoking, and bone availability.

What HbA1c do I need?

There is no single agreed threshold, and anyone quoting one as an absolute should be questioned. Better control is associated with better outcomes across the range, and treatment planning takes your individual figures and trend into account alongside everything else. A recent result is worth bringing to the consultation.

Will my implants take longer to heal?

Generally yes. Studies show integration develops more slowly, which is why healing periods before loading are commonly extended. The difference is measured in weeks to months rather than being a fundamental change in the process.

Am I more likely to lose an implant later?

The risk of peri-implantitis is higher, particularly with poorer control, and peri-implantitis is the main cause of late implant loss. This risk is substantially modifiable through maintenance and glycaemic control, which is why the maintenance programme is emphasised more heavily.

Should my GP or diabetes team be involved?

Ideally yes, particularly if control has been variable or if complications are present. Coordinating the timing of surgery with your diabetes care is sensible, and a recent HbA1c and medication list are useful for planning.

Will treating my gums help my diabetes?

There is evidence that periodontal treatment produces a modest improvement in HbA1c, which is one of the better-supported findings in the oral-systemic literature. It is not a substitute for diabetes management, but it is a worthwhile contribution. Our article on how oral health influences chronic disease covers the evidence.

What if my control is currently poor?

The usual recommendation is to work with your diabetes team to improve it before elective surgery, and to revisit the plan once it has. This is a delay rather than a refusal, and in the interim other options for replacing missing teeth can be discussed.

If you have diabetes and are considering implants, bring a recent HbA1c result, a list of your medications, and details of your diabetes care team. Those three things allow a realistic conversation at the first appointment rather than after a delay.

Having been told no elsewhere does not necessarily mean the answer is no, particularly if the assessment was based on the diagnosis rather than on your control.

You can contact our team to arrange an assessment at our Wimpole Street practice. Our dental implants and gum disease treatment pages explain what is involved.

This article provides general information and does not constitute individual dental or medical advice. Suitability for implant treatment can only be determined following clinical examination, imaging and review of your medical history in conjunction with your medical team. Do not alter your diabetes medication without advice from the clinician managing your diabetes. Implant treatment carries surgical risks, requires lifelong maintenance, and outcomes vary between individuals. Wimpole Dental is regulated by the Care Quality Commission, and our clinicians are registered with the General Dental Council.

Next review due: 12 September 2027